Literature DB >> 17039693

Pregnancy-related changes in the size of uterine leiomyomas.

Ran Neiger1, Jiri D Sonek, Christopher S Croom, Gary Ventolini.   

Abstract

OBJECTIVE: To describe the effects of pregnancy on the growth of leiomyomas using sonographic measurements of leiomyomas taken longitudinally during pregnancy. STUDY
DESIGN: The study population included asymptomatic gravidas with singleton pregnancies in whom we identified uterine leiomyomas. We included all women whose leiomyomas were measured at least twice during the pregnancy. In a subgroup of women we also compared the size of leiomyomas before and after the index pregnancy. Using real-time sonography, we measured each leiomyoma in 3 axes and averaged the measurements. During subsequent studies we calculated the percent change in the size of each tumor. We assessed complications related to the presence of these tumors.
RESULTS: We evaluated 137 leiomyomas in 72 women (average, 2.3 +/- 1.8 per woman). Each underwent an average of 3.7 +/- 2.1 scans. The average gestational age at the time of first assessment was 14.4 +/- 5.4 weeks. The average diameter of the leiomyomas at the first study was 34.2 +/- 23 mm. On average, there was no significant change in the size of leiomyomas during pregnancy. We found that the size, location and our ability to visualize leiomyomas varied significantly during pregnancy. Four of the 72 women had obstetric complications related to the presence of leiomyomas.
CONCLUSION: The findings of our longitudinal sonographic assessment of 137 uterine leiomyomas suggest that despite the commonly held belief that they tend to enlarge during the course of pregnancy, this phenomenon is in fact quite rare.

Entities:  

Mesh:

Year:  2006        PMID: 17039693

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  22 in total

1.  Pregnancy-related fibroid reduction.

Authors:  Shannon K Laughlin; Amy H Herring; David A Savitz; Andrew F Olshan; Julia R Fielding; Katherine E Hartmann; Donna D Baird
Journal:  Fertil Steril       Date:  2010-05-07       Impact factor: 7.329

Review 2.  The role of progesterone signaling in the pathogenesis of uterine leiomyoma.

Authors:  J Julie Kim; Elizabeth C Sefton
Journal:  Mol Cell Endocrinol       Date:  2011-06-06       Impact factor: 4.102

3.  Progesterone is essential for maintenance and growth of uterine leiomyoma.

Authors:  Hiroshi Ishikawa; Kazutomo Ishi; Vanida Ann Serna; Rafael Kakazu; Serdar E Bulun; Takeshi Kurita
Journal:  Endocrinology       Date:  2010-04-07       Impact factor: 4.736

Review 4.  Progesterone receptor action in leiomyoma and endometrial cancer.

Authors:  J Julie Kim; Elizabeth C Sefton; Serdar E Bulun
Journal:  Prog Mol Biol Transl Sci       Date:  2009-10-07       Impact factor: 3.622

5.  Uterine leiomyomata and cesarean birth risk: a prospective cohort with standardized imaging.

Authors:  Kara A Michels; Digna R Velez Edwards; Donna D Baird; David A Savitz; Katherine E Hartmann
Journal:  Ann Epidemiol       Date:  2013-11-12       Impact factor: 3.797

Review 6.  Leiomyomata uteri: hormonal and molecular determinants of growth.

Authors:  Richard Enrique Blake
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

7.  Sonographic assessment of pregnancy co-existing with uterine leiomyoma in Owerri, Nigeria.

Authors:  C U Eze; E A Odumeru; K Ochie; U I Nwadike; K K Agwuna
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

8.  Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells.

Authors:  Xia Luo; Ping Yin; Scott Reierstad; Hiroshi Ishikawa; Zhihong Lin; Mary Ellen Pavone; Hong Zhao; Erica E Marsh; Serdar E Bulun
Journal:  J Clin Endocrinol Metab       Date:  2009-10-06       Impact factor: 5.958

9.  Reproductive outcomes following robotic-assisted laparoscopic myomectomy (RALM).

Authors:  Olga A Tusheva; Anthony Gyang; Sejal D Patel
Journal:  J Robot Surg       Date:  2012-05-13

Review 10.  Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.

Authors:  J Julie Kim; Takeshi Kurita; Serdar E Bulun
Journal:  Endocr Rev       Date:  2013-01-09       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.